These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 31266409)

  • 1. Distress Tolerance and Symptom Severity as Mediators of Symptom Validity Failure in Veterans With PTSD.
    Miskey HM; Martindale SL; Shura RD; Taber KH
    J Neuropsychiatry Clin Neurosci; 2020; 32(2):161-167. PubMed ID: 31266409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the relationship between symptom and performance validity measures across referral subtypes.
    Boress K; Gaasedelen O; Kim JH; Basso MR; Whiteside DM
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):162-171. PubMed ID: 37791494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of validity testing in psychiatric assessment: evidence from a sample of multimorbid post-9/11 veterans.
    Kim S; Currao A; Brown E; Milberg WP; Fortier CB
    J Int Neuropsychol Soc; 2024 May; 30(4):410-419. PubMed ID: 38014547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Importance of the Morel Emotional Numbing Test Instructions: A Diagnosis Threat Induction Study.
    Williamson ES; Arentsen TJ; Roper BL; Pedersen HA; Shultz LA; Crouse EM
    Arch Clin Neuropsychol; 2024 Jan; 39(1):35-50. PubMed ID: 37449530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional Malingering Criteria for Neuropsychological Assessment: A 20-Year Update of the Malingered Neuropsychological Dysfunction Criteria.
    Sherman EMS; Slick DJ; Iverson GL
    Arch Clin Neuropsychol; 2020 Aug; 35(6):735-764. PubMed ID: 32377667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom and performance validity in neuropsychological assessments of outpatients 15-30 years of age.
    Boe EW; Evald L
    Brain Inj; 2022 Dec; ():1-7. PubMed ID: 36527248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of PCL-5 symptom validity indices for detection of exaggerated and feigned PTSD.
    Schroeder RW; Bieu RK
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):152-161. PubMed ID: 38353609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 10. Base Rates of Performance and Symptom Validity Test Failures in Active Duty and Veteran Samples Referred for Attention-Deficit/Hyperactivity Disorder Evaluation.
    Shura RD; Armistead-Jehle P
    Arch Clin Neuropsychol; 2024 May; 39(4):523-527. PubMed ID: 38073319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The main and interactive effects of distress tolerance and reward function on posttraumatic stress disorder symptoms among firefighters.
    Zegel M; McGrew SJ; Wardle MC; Vujanovic AA
    Psychol Trauma; 2023 Sep; 15(Suppl 2):S319-S326. PubMed ID: 35482680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive "success" in the setting of performance validity test failure.
    Tierney SM; Matchanova A; Miller BI; Troyanskaya M; Romesser J; Sim A; Pastorek NJ
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):46-54. PubMed ID: 37555316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological distress mediates the association between COVID-19-related discrimination and subsequent PTSD symptom severity in healthcare workers: a two-year follow-up study.
    Narita Z; Okubo R; Sasaki Y; Takeda K; Takao M; Komaki H; Oi H; Miyama T; Kim Y
    BMC Public Health; 2024 Jul; 24(1):1834. PubMed ID: 38982334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying failure criteria on performance validity tests influences interpretation of cognitive outcomes.
    Tierney SM; Taiwo Z; Choudhury TK; Lippa SM; Troyanskaya M; Pastorek NJ; Miller B; Romesser J; Sim A
    Neuropsychology; 2023 Jan; 37(1):93-103. PubMed ID: 36227290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMG measured reaction time as a predictor of invalid symptom report in psychosomatic patients.
    Weymann T; Achenbach J; Guevara JE; Bassler M; Karst M; Lambrecht A
    Clin Neuropsychol; 2024 Jul; 38(5):1210-1226. PubMed ID: 37917133
    [No Abstract]   [Full Text] [Related]  

  • 16. Childhood Trauma and PTSD Symptoms: Disentangling the Roles of Emotion Regulation and Distress Tolerance.
    Russo JE; Dhruve DM; Oliveros AD
    Res Child Adolesc Psychopathol; 2023 Sep; 51(9):1273-1287. PubMed ID: 37039922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Main and Interactive Effects of Distress Tolerance and Negative Affect Intensity in Relation to PTSD Symptoms among Trauma-Exposed Adults.
    Vujanovic AA; Hart AS; Potter CM; Berenz EC; Niles B; Bernstein A
    J Psychopathol Behav Assess; 2013 Jun; 35(2):235-243. PubMed ID: 24431482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Nomological Network of a Behavioral Distress Tolerance Task in Veterans.
    Brown RC; Overstreet C; Sheerin C; Berenz E; Hawn S; Pickett T; McDonald S; Danielson CK; Amstadter AB
    J Trauma Stress; 2018 Dec; 31(6):876-885. PubMed ID: 30537021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom attribution is a stronger predictor of PVT-failure than symptom endorsement in treatment-seeking Veterans with remote mTBI history: A pilot study.
    Ton Loy AF; Lee JE; Asimakopoulos G; Sakamoto MS; Merritt VC
    Appl Neuropsychol Adult; 2023 Dec; ():1-6. PubMed ID: 38113857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montreal Cognitive Assessment as a screening tool: Influence of performance and symptom validity.
    Waldron-Perrine B; Gabel NM; Seagly K; Kraal AZ; Pangilinan P; Spencer RJ; Bieliauskas L
    Neurol Clin Pract; 2019 Apr; 9(2):101-108. PubMed ID: 31041123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.